LUNSUMIO

This brand name is authorized in United States. It is also authorized in Austria, Croatia, Cyprus, Estonia, Finland, France, Ireland, Israel, Italy, Lithuania, Poland, Romania, UK.

Active ingredients

The drug LUNSUMIO contains one active pharmaceutical ingredient (API):

1
UNII LDJ89SS0YG - MOSUNETUZUMAB
 

Mosunetuzumab is an anti-CD20/CD3 T-cell engaging bispecific antibody targeting CD20-expressing B-cells. It is a conditional agonist; targeted B-cell killing is observed only upon simultaneous binding to CD20 on B-cells and CD3 on T-cells. Engagement of both arms of mosunetuzumab results in the formation of an immunologic synapse between a target B cell and a cytotoxic T cell leading to T-cell activation. Subsequent directed release of perforin and granzymes from T-cell activation through the immunologic synapsis induce B-cell lysis leading to cell death.

 
Read more about Mosunetuzumab

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 LUNSUMIO Concentrate for solution for infusion MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
L01XC † Monoclonal antibodies L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents
Discover more medicines within L01XC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1885259, 1885260
FI Lääkealan turvallisuus- ja kehittämiskeskus 481789, 511433
FR Base de données publique des médicaments 64119565, 64499808
IL מִשְׂרַד הַבְּרִיאוּת 9222, 9436
IT Agenzia del Farmaco 050151012, 050151024
LT Valstybinė vaistų kontrolės tarnyba 1094946, 1094947
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W68902001, W68903001
US FDA, National Drug Code 50242-142, 50242-159

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.